Evidence map›Paper›PMID 24955763›Full record

ArticlePloS one2014

CRISPLD2 is a target of progesterone receptor and its expression is decreased in women with endometriosis.

Jung-Yoon Yoo, Heesung Shin, Tae Hoon Kim, Won-Seok Choi, Susan D Ferguson, Asgerally T Fazleabas, Steven L Young, Bruce A Lessey, Un-Hwan Ha, Jae-Wook Jeong

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Endometrial biomarkers for the non-invasive diagnosis of endometriosis.The Cochrane database of systematic reviews · 2016
    Pooled it
  2. Sex-specific effects ofVeterinary world · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Uterine double-conditional inactivation ofProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Jung-Yoon YooDepartment of Obstetrics, Gynecology & Reproductive Biology, Michigan State University, College of Human Medicine, Grand Rapids, Michigan, United States of America.
Heesung ShinDepartment of Obstetrics, Gynecology & Reproductive Biology, Michigan State University, College of Human Medicine, Grand Rapids, Michigan, United States of America; Department of Biotechnology and Bioinformatics, Korea University, Sejong, South Korea.
Tae Hoon KimDepartment of Obstetrics, Gynecology & Reproductive Biology, Michigan State University, College of Human Medicine, Grand Rapids, Michigan, United States of America.
Won-Seok ChoiDepartment of Food Science and Technology, Korea National University of Transportation, Chungbuk, South Korea.
Susan D FergusonDepartment of Obstetrics, Gynecology & Reproductive Biology, Michigan State University, College of Human Medicine, Grand Rapids, Michigan, United States of America.
Asgerally T FazleabasDepartment of Obstetrics, Gynecology & Reproductive Biology, Michigan State University, College of Human Medicine, Grand Rapids, Michigan, United States of America.
Steven L YoungDepartment of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Bruce A LesseyDepartment of Obstetrics and Gynecology, University Medical Group, Greenville Hospital System, Greenville, South Carolina, United States of America.
Un-Hwan HaDepartment of Biotechnology and Bioinformatics, Korea University, Sejong, South Korea.
Jae-Wook JeongDepartment of Obstetrics, Gynecology & Reproductive Biology, Michigan State University, College of Human Medicine, Grand Rapids, Michigan, United States of America.
Michigan State University · USKorea University · KRGrand Rapids Community College · USKorea National University of Transportation · KRMichigan United · USPrisma Health · USUniversity of North Carolina at Chapel Hill · US

Funding

Progesterone Action in the Endometrium of Women with EndometriosisR01HD067721 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI YOUNG, STEVEN L · 2011 to 2015
$3.1M
Steroid Hormone Regulation of Uterine Function and DysfunctionR01HD057873 · NICHD · MICHIGAN STATE UNIVERSITY · PI JEONG, JAE-WOOK · 2008 to 2012
$1.3M
NICHD NIH HHS R01 HD057873NICHD NIH HHS R01 HD067721
6 · The paper itself

Abstract

Endometriosis, defined as the presence of endometrial cells outside of the uterine cavity, is a major cause of infertility and pelvic pain, afflicting more than 10% of reproductive age women. Endometriosis is a chronic inflammatory disease and lipopolysaccharide promotes the proliferation and invasion of endometriotic stromal cells. Cysteine-rich secretory protein LCCL domain-containing 2 (CRISPLD2) has high affinity for lipopolysaccharide and plays a critical role in defense against endotoxin shock. However, the function of CRISPLD2 has not been studied in endometriosis and uterine biology. Herein, we examined the expression of CRISPLD2 in endometrium from patients with and without endometriosis using immunohistochemistry. The expression of CRISPLD2 was higher in the secretory phase in human menstrual cycle compared to proliferative phase. The expression of CRISPLD2 was significantly decreased in the endometrium of women with endometriosis in the early secretory phase compared to women without endometriosis. The increase of CRISPLD2 expression at the early secretory and dysregulation of its expression in endometriosis suggest progesterone (P4) regulation of CRISPLD2. To investigate whether CRISPLD2 is regulated by P4, we examined the expression of the CRISPLD2 in the uteri of wild-type and progesterone receptor knock out (PRKO) mice. The expression of CRISPLD2 was significantly increased after P4 treatment in the wild-type mice. However, CRISPLD2 expression was significantly decreased in the (PRKO) mice treated with P4. During early pregnancy, the expression of CRISPLD2 was increased in decidua of implantation and post-implantation stages. CRISPLD2 levels were also increased in cultured human endometrial stromal cells during in vitro decidualization. These results suggest that the CRISPLD2 is a target of the progesterone receptor and may play an important role in pathogenesis of endometriosis.

Indexed as

AdolescentAdultAnimalsBlotting, WesternCell Adhesion MoleculesEndometriosisEndometriumFemaleHumansImmunoenzyme TechniquesInterferon Regulatory FactorsMenstrual CycleMiceMice, Inbred C57BLMice, KnockoutMiddle AgedCell Adhesion MoleculesCRISPLD2 protein, humanInterferon Regulatory FactorsProgesteroneReceptors, ProgesteroneRNA, Messenger

Identifiers

PMID24955763
PMCPMC4067330
OpenAlexW2015627512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.